PATENT CLAIM ANALYSIS

Application Number: 16124846
Application Type: Utility
Filing Date: 2018-09
Publication Date: 2019-01
Patent Classification: ["544", "238000"]

Abstract:
Provided are compounds having metalloenzyme modulating activity, and methods of treating diseases, disorders or symptoms thereof mediated by such metalloenzymes.

Claim (Index 70):
The method of  claim 66 , wherein the disorder or disease is cancer, cardiovascular disease, endocrinologic disease, inflammatory disease, infectious disease, gynecologic disease, metabolic disease, ophthalmologic disease, central nervous system (CNS) disease, urologic disease, or gastrointestinal disease.

Metadata:
- Claim Count in Document: 59.0
- Percentile: 97.0
- Lexical Diversity: 1.04545
- Patent Class: 544.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['15857950', '15858015', '14776280', '13651312', '14580045']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.8112570452284307
- 35 USC 102 Novelty (BERT): 0.5648365689195692
- Combined Prediction Score: 0.7866149975975445
- Mean Citation Score: 449.73928000000006
- Max Citation Score: 604.79395
- Similarity Product: 304.1906776836932

Labels:
- Claim Label 101: 1
- Claim Label 102: 0
- Claim Label 103: 1
- Claim Label 112: 0
- Combined Label: 0
- Label 101 Adjusted: 1

Dataset: test